1. a preclinical stage of Alzheimer’s Disease,
2. the mild cognitive impairment (MCI) stage due to AD and
3. dementia stage due to AD.
Tau w/o phosphor T175/T181 in CSF shows at least comparable diagnostic specificity and sensitivity to other diagnostic available tests for Alzheimer’s disease.
Specifications:
3.5h protocol; 50 µl CSF required
Cut-Off: 78 pg/ml (each laboratory must establish its own Cut-Off values)
Analytical Sensitivity (Limit of detection): 12 pg/ml (Mean signal negative control (blank) + 3xSD)
Clinical Sensitivity: 95% (AD/MCI patients: n=58, Controls: n=42)
Clinical Specifity: 98% (AD/MCI patients: n=58, Controls: n=42)
Area under ROC-curve (AUC): 97.4%